Insider buying last 90 days
No open-market insider purchases were filed for EXPO in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every EXPO insider filing, plotted on the chart in Gekko.Open EXPO in Gekko
NASDAQ: EXPO
Exponent (EXPO) Stock Analysis & Forecast
Oct 12 close
$70.67+0.86 (+1.2%)
Gekko Brief
AI summaryOct 12 closeExponent's recent news centers on the upcoming scheduling of its third-quarter fiscal year 2026 results, confirmed for 29 October 2026 after market close, with the CEO, President, EVP and CFO hosting a conference call. A placeholder stock-forecast article also circulated. Separately, a 13F filing showed Corient Private Wealth LP trimming its stake in Exponent by 81.2% in the second quarter.
Exponent closed at $70.67, up 1.2%, sitting above both its 50-day average of $68.17 and 200-day average of $66.39, with the shorter average above the longer one. The stock's one-month return stands at 5.1% and its three-month return at 13.8%, within a 52-week range of $51.91 to $81.95. The GekkoIndex reads 50.6, placing it in the Neutral zone, down 4 points over five days. Price sits 3.2% above Gekko Fair Value of $68.49.
The next earnings date falls on 29 October 2026, 17 days away and within a typical 20-trading-day holding period; the prior quarter saw a 1.5% reaction with EPS of $0.60 against a $0.55 estimate, part of a run of 7 beats in the last 8 quarters, with an average absolute reaction of 4.9%. Seasonality over the next 20 trading days has averaged -0.3% across 5 years, rising in 3 of them. No insider, Congress or unusual options activity appears in the respective windows, and consensus among 4 firms shows 3 buy ratings and 1 hold, with a consensus target of $84.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Exponent price vs fair value
Close $70.67200-day averageGekko Fair Value $68.49
Exponent quick facts
- Market cap
- $3.43B
- P/E ratio
- 31.3
- Forward P/E
- 31.6
- EPS, TTM
- $2.23
- Revenue, TTM
- $567.1M
- Profit margin
- 19.7%
- Dividend yield
- 1.77%
- Beta
- 0.70
- Volume
- 462,861 avg 567,963
- 1-year return
- +8.3%
- Typical daily move
- ±2.7%
- Typical 20-day move
- ±4.9%
- 50-day average
- $68.17
- 200-day average
- $66.39
- Next earnings
- Oct 29 after close
- Shares outstanding
- 47.55M
Exponent swing-trade checklist
Exponent scores 1 supportive, 3 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
1 supportive3 mixed1 headwind
- Trendsupportive
Above 50 and 200-day
Close $70.67 is above the 50-day ($68.17) and 200-day ($66.39) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
50.6, Neutral
Reading 50.6 is in the Neutral zone.
See the GekkoIndex - Fair valuemixed
3.2% above
Price is within 5% of Gekko Fair Value (3.2% above).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskheadwind
Reports in 17 days
Reports on Oct 29, 2026, 17 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalitymixed
−0.3% on average
From this point in the calendar, the next 20 trading days averaged −0.3% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Exponent stock chart and price history
Exponent closed at $70.67 on Oct 12, 2026, +8.3% over the past year, inside a 52-week range of $51.91 to $81.95.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +5.1%
- 3 months
- +13.8%
- 6 months
- +6.1%
- 1 year
- +8.3%
The full EXPO chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open EXPO in Gekko
Follow Exponent through every session
Put EXPO on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track EXPO in GekkoFree for 7 days. No credit card required.
Exponent GekkoIndex: the smart money zone
Exponent’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 50.6, in the Neutral zone, down 4 points over five sessions.
50.6Neutral
Down 4 points over five sessions.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 54 | +1.5% | +0.9% | ||
| Accumulation | 273 | −0.1% | −1.1% | ||
| Neutral (current zone) | 337 | −0.4% | −0.1% | ||
| Distribution | 17 | +0.8% | −1.0% | ||
| Selling | 1 | Too few readings yet | |||
Average EXPO share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the EXPO price, zone by zone.Track EXPO in Gekko
Is Exponent stock overvalued? Gekko Fair Value
Exponent trades 3.2% above Gekko Fair Value of $68.49, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Exponent shares are worth, recalculated every trading day.
$68.49
Gekko Fair Value, Oct 10, 2026
3.2% above fair value · About fair value
At the end of Aug 2026 the price was 0.2% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open EXPO in Gekko
Exponent insider and Congress trading
No open-market insider purchases were filed for Exponent, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in EXPO were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for EXPO, plotted on the chart in Gekko.Open EXPO in Gekko
Buybacks
Exponent has been buying back its own shares.
- Latest authorization
- $50.00M, Jul 30, 2026
- Bought back, quarter ended Jul 3, 2026
- $67.38M
- As a share of market cap
- 1.97%
- Trailing four quarters
- $210.6M
From company filings.
Hedge funds and billionaires quarter ended Sep 30
0of the funds Gekko tracks hold EXPO.
0added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Exponent earnings: next date and track record
Exponent reports on Oct 29, 2026, after the close (17 days away), and beat the EPS estimate in 7 of its last 8 reports.
Next earnings report
Oct 29, 2026
Expected after the close, 17 days away
- EPS estimate
- $0.60
- Revenue estimate
- $149.5M
7 of 8reports beat the EPS estimate
±4.9%average move across the report
3 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 30, 2026 AI summary
- What they said
- Exponent delivered double-digit revenue and earnings growth in Q2 2026, driven by strong proactive work in AI-enabled product user research studies and utility sector risk management engagements. Reactive work also grew with demand for dispute-related expertise in consumer products, chemicals, and transportation. A large user research study drove higher-than-expected revenue and utilization. The company's multidisciplinary expertise across human factors, biomechanics, engineering, and data science positions it well as AI product complexity increases.
- Guidance
- No explicit financial guidance, revenue targets, or earnings forecasts were provided in this transcript excerpt. Eric Anderson's financial results and outlook section was referenced but not included in the provided text.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 30, 2026 | $0.60 est $0.55 | $148.9M est $145.0M | +1.5% |
| Apr 30, 2026 | $0.59 est $0.61 | $151.8M est $149.5M | −1.4% |
| Feb 5, 2026 | $0.49 est $0.47 | $129.4M est $128.1M | +13.8% |
| Oct 30, 2025 | $0.55 est $0.50 | $147.1M est $128.5M | +8.3% |
| Jul 31, 2025 | $0.52 est $0.48 | $142.0M est $132.1M | −0.7% |
| May 1, 2025 | $0.52 est $0.48 | $145.5M est $134.6M | −2.4% |
| Feb 6, 2025 | $0.46 est $0.40 | $136.8M est $119.6M | −1.8% |
| Oct 24, 2024 | $0.50 est $0.48 | $136.3M est $121.0M | −9.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Exponent stock forecast and analyst price targets
Analysts’ average 12-month price target for Exponent is $84.00, +18.9% from the last close, from 4 firms rating the stock in the last 90 days.
$84.00consensus 12-month target, +18.9% from the last close
Now $70.67Avg $84.00
Low $72High $90
Each firm’s latest rating in the last 90 days: 4 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 30 | William Blair | — | — |
| Sep 30 | Truist Financial | $90 | +27.4% |
| Jul 31 | Truist Financial | $90 | +27.4% |
| Jul 31 | J.P. Morgan | $90 | +27.4% |
| Jul 31 | UBS | $72 | +1.9% |
−0.1%average 20-day move after past Neutral readings
−0.3%average move over the next 20 trading days in the last 5 years
±2.7%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Exponent seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, Exponent averaged −0.3% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.9% | 3 of 5 |
| Next 10 trading days | −0.6% | 3 of 5 |
| Next 15 trading days | −3.3% | 3 of 5 |
| Next 20 trading days | −0.3% | 3 of 5 |
| Next 30 trading days | +0.9% | 3 of 5 |
For scale, EXPO’s typical 20-trading-day move in either direction is about 4.9%.
Exponent market cap and key statistics
Exponent’s market cap is $3.43B, with a P/E ratio of 31.3 and revenue of $567.1M over the last twelve months.
Valuation
- Market cap
- $3.43B
- P/E ratio
- 31.3
- Forward P/E
- 31.6
- EPS, TTM
- $2.23
- Gekko Fair Value
- $68.49
Trading
- Volume
- 462,861
- Avg volume, 20 days
- 567,963
- 52-week high
- $81.95
- 52-week low
- $51.91
- Shares outstanding
- 47.55M
Financials
- Revenue, TTM
- $567.1M
- Profit margin
- 19.7%
- Return on equity
- 31.2%
- Quarterly earnings growth, YoY
- +15.7%
Risk and income
- Beta
- 0.70
- Typical daily move
- ±2.7%
- Typical 20-day move
- ±4.9%
- Dividend yield
- 1.77%
Exponent stock news this week
3 headlines about Exponent from the past week, newest first, each linking to the publisher.
- Exponent, Inc. (EXPO) Stock forecastsYahoo Finance UK, Oct 9
- Exponent to Announce Third Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on October 29, 2026Supply Chain Digital, Oct 9
- Corient Private Wealth LP Trims Stake in Exponent, Inc. $EXPODefense World, Oct 5
Exponent peers
Exponent’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| PWRQuanta Services | Neutral | 12.7% above |
| FIXComfort Systems USA | Neutral | 4.1% above |
| FERFerrovial | Accumulation | 26.0% below |
| EMEEMCOR | Neutral | 6.5% above |
| OTISOtis Worldwide | Neutral | 15.9% below |
| APGAPi | Neutral | 5.6% above |
A peer links to its own page where one exists.
Exponent stock FAQ
What is Exponent’s market cap?
Exponent’s market cap is $3.43B at the Oct 12, 2026 close of $70.67, with 47.55M shares outstanding. The shares trade on a P/E ratio of 31.3.
What is the Exponent stock forecast?
The consensus analyst 12-month price target for Exponent is $84.00, +18.9% from the last close. Of the 4 firms that rated the stock in the last 90 days, 3 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Exponent stock overvalued or undervalued?
On Gekko’s estimate Exponent is about fair value: the Oct 12, 2026 close of $70.67 is 3.2% above Gekko Fair Value of $68.49. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Exponent report earnings next?
Exponent is expected to report on Oct 29, 2026, after the market closes (17 days away). Analysts expect earnings of $0.60 per share on revenue of $149.5M. Exponent beat the earnings estimate in 7 of its last 8 reports, moving 4.9% on average across the report.
What is Exponent’s 52-week high and low?
Exponent’s 52-week high is $81.95 and its 52-week low is $51.91; it closed at $70.67 on Oct 12, 2026, +8.3% over the past year. Over the last five years the shares peaked at $127.61 on Nov 22, 2021.
Is Exponent stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 1 of the 5 items with data read as supportive (trend), 3 as mixed (gekkoindex, fair value and seasonality) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Exponent the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.